Use of Multistate Models to Assess Prolongation of Intensive Care Unit Stay Due to Nosocomial Infection

Background. Reliable data on the costs attributable to nosocomial infection (NI) are crucial to demonstrating the real cost-effectiveness of infection control measures. Several studies investigating this issue with regard to intensive care unit (ICU) patients have probably overestimated, as a result of inappropriate study methods, the part played by NIs in prolonging the length of stay. Methods. Data from a prospective study of the incidence of NI in 5 ICUs over a period of 18 months formed the basis of this analysis. For describing the temporal dynamics of the data, a multistate model was used. Thus, ICU patients were counted as case patients as soon as an NI was ascertained on any particular day. All patients were then regarded as control subjects as long as they remained free of NI (time-to-event data analysis technique). Results. Admitted patients (n = 1,876) were observed for the development of NI over a period of 28,498 patient-days. In total, 431 NIs were ascertained during the study period (incidence density, 15.1 NIs per 1,000 patient-days). The influence of NI as a time-dependent covariate in a proportional hazards model was highly significant (P< .0001, Wald test). NI significantly reduced the discharge hazard (hazard ratio, 0.72 [95% confidence interval, 0.63-0.82])—that is, it prolonged the ICU stay. The mean prolongation of ICU length of stay due to NI ( ± standard error) was estimated to be 5.3 ± 1.6 days. Conclusions. Further studies are required to enable comparison of data on prolongation of ICU length of stay with the results of various study methods.

[1]  J. Alexander,et al.  Cost evaluation of infections in intensive care. , 1983, Acta anaesthesiologica Belgica.

[2]  C. Craig,et al.  Effect of intensive care unit nosocomial pneumonia on duration of stay and mortality. , 1984, American journal of infection control.

[3]  J M Hughes,et al.  CDC definitions for nosocomial infections, 1988. , 1988, American journal of infection control.

[4]  R. Woolson,et al.  Hospital-acquired pneumonia. Attributable mortality and morbidity. , 1989, American journal of epidemiology.

[5]  B. Yangco,et al.  CDC definitions for nosocomial infections. , 1989, American journal of infection control.

[6]  M. Schumacher,et al.  Added Hospital Stay Due to Wound Infections Following Cardiac Surgery , 1992, The Thoracic and cardiovascular surgeon.

[7]  R. Gaynes,et al.  CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. , 1992, Infection control and hospital epidemiology.

[8]  A. B. Cavanillas,et al.  The estimation of the cost of nosocomial infection in an intensive care unit , 1993 .

[9]  P. Montravers,et al.  Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. , 1993, The American journal of medicine.

[10]  A. Bueno Cavanillas,et al.  [The estimation of the cost of nosocomial infection in an intensive care unit]. , 1993, Medicina clinica.

[11]  D. Pittet,et al.  Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. , 1994, JAMA.

[12]  James F. Watkins,et al.  Analysing Survival Data from Clinical Trials and Observational Studies. , 1995 .

[13]  E. Haponik,et al.  Pneumonia in intubated trauma patients. Microbiology and outcomes. , 1996, American journal of respiratory and critical care medicine.

[14]  J. Dumon,et al.  Effect of ventilator-associated pneumonia on mortality and morbidity. , 1996, American journal of respiratory and critical care medicine.

[15]  M Schumacher,et al.  Estimation of prolongation of hospital stay attributable to nosocomial infections: New approaches based on multistate models , 1996, Lifetime data analysis.

[16]  M. Safar,et al.  Risk factors and outcome of nosocomial infections: results of a matched case-control study of ICU patients. , 1998, American journal of respiratory and critical care medicine.

[17]  M. Higgins,et al.  The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. , 1999, American journal of respiratory and critical care medicine.

[18]  D. Cook,et al.  The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. , 1999, American journal of respiratory and critical care medicine.

[19]  M. Schumacher,et al.  Estimation of extra hospital stay attributable to nosocomial infections: heterogeneity and timing of events. , 2000, Journal of clinical epidemiology.

[20]  J. Rello,et al.  Evaluation of outcome of intravenous catheter-related infections in critically ill patients. , 2000, American journal of respiratory and critical care medicine.

[21]  C. Brun-Buisson,et al.  Outcomes of primary and catheter-related bacteremia. A cohort and case-control study in critically ill patients. , 2001, American journal of respiratory and critical care medicine.

[22]  N Keiding,et al.  Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: Unadjusted analysis , 2001, Bone Marrow Transplantation.

[23]  R Consunji,et al.  Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. , 2001, Archives of surgery.

[24]  R. Gray Modeling Survival Data: Extending the Cox Model , 2002 .

[25]  Jordi Rello,et al.  Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. , 2002, Chest.

[26]  Joseph D. Conklin Classical Competing Risks , 2002, Technometrics.

[27]  Susanne Rosthøj,et al.  Competing risks as a multi-state model , 2002, Statistical methods in medical research.

[28]  N. Keiding,et al.  Multi-state models for event history analysis , 2002, Statistical methods in medical research.

[29]  H. Rüden,et al.  Five years working with the German nosocomial infection surveillance system (Krankenhaus Infektions Surveillance System). , 2003, American journal of infection control.

[30]  W. Trick,et al.  The use of economic modeling to determine the hospital costs associated with nosocomial infections. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  Carl van Walraven,et al.  Time-dependent bias was common in survival analyses published in leading clinical journals. , 2004, Journal of clinical epidemiology.

[32]  M. Schumacher,et al.  Prolongation of hospital stay and extra costs due to ventilator-associated pneumonia in an intensive care unit , 1992, European Journal of Clinical Microbiology and Infectious Diseases.

[33]  Martin Schumacher,et al.  How many infections are caused by patient-to-patient transmission in intensive care units?* , 2005, Critical care medicine.

[34]  M. Schumacher,et al.  Validation of Surveillance in the Intensive Care Unit Component of the German Nosocomial Infections Surveillance System , 2007, Infection Control &#x0026; Hospital Epidemiology.

[35]  M. Kenward,et al.  An Introduction to the Bootstrap , 2007 .